Fondazione Telethon   Report issue

Foundation Phase 2 Phase 3
Founded: Milano Italy (1990)

Organization Overview

First Clinical Trial
1992
NCT00599781
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Fondazione Telethon